Serum levels of proteins involved in amyloid‐β clearance are related to cognitive decline and neuroimaging changes in mild cognitive impairment. Issue 1 (18th December 2018)
- Record Type:
- Journal Article
- Title:
- Serum levels of proteins involved in amyloid‐β clearance are related to cognitive decline and neuroimaging changes in mild cognitive impairment. Issue 1 (18th December 2018)
- Main Title:
- Serum levels of proteins involved in amyloid‐β clearance are related to cognitive decline and neuroimaging changes in mild cognitive impairment
- Authors:
- Liu, Shan
Suzuki, Hideaki
Ito, Hitomi
Korenaga, Tatsumi
Akatsu, Hiroyasu
Meno, Kohji
Uchida, Kazuhiko - Editors:
- Zetterberg, Henrik
- Abstract:
- Abstract: Introduction: Amyloid‐β (Aβ) clearance is important for damage prevention in Alzheimer's disease. We investigated the utility of Aβ clearance proteins as biomarkers for mild cognitive impairment (MCI). Methods: Serum apolipoprotein (apo) A‐I, compliment protein C3 (C3), transthyretin, and cholesterol levels were measured in 273 subjects, and we analyzed the relationship between these levels and brain atrophy and cerebral blood flow in 63 clinically diagnosed mild cognitive impairment, Alzheimer's disease, and nondemented disease control subjects. Results: ApoA‐I and transthyretin levels and the active form of C3:native form of C3 ratio achieved an area under the curve of 0.89 (sensitivity: 83%, specificity: 90%) for detecting late mild cognitive impairment. Atrophy was associated with decreased apoA‐I and high‐density lipoprotein levels. Subjects with reduced cerebral blood flow had lower levels of native form of C3, apoA‐I, high‐density lipoprotein, and total cholesterol. Low native form of C3 and high active form of C3 levels were found in the hippocampi of patients with Alzheimer's disease. Discussion: Aβ clearance proteins in the serum are potential biomarkers for mild cognitive impairment evaluation.
- Is Part Of:
- Alzheimer's & dementia. Volume 11:Issue 1(2019)
- Journal:
- Alzheimer's & dementia
- Issue:
- Volume 11:Issue 1(2019)
- Issue Display:
- Volume 11, Issue 1 (2019)
- Year:
- 2019
- Volume:
- 11
- Issue:
- 1
- Issue Sort Value:
- 2019-0011-0001-0000
- Page Start:
- 85
- Page End:
- 97
- Publication Date:
- 2018-12-18
- Subjects:
- Alzheimer's disease -- Biomarker -- Complement protein -- Microglia -- Neuroinflammation
Alzheimer's disease -- Periodicals
Alzheimer's disease -- Diagnosis -- Periodicals
Dementia -- Periodicals
Dementia -- Diagnosis -- Periodicals
616.831 - Journal URLs:
- https://alz-journals.onlinelibrary.wiley.com/loi/23528729 ↗
http://www.sciencedirect.com/ ↗ - DOI:
- 10.1016/j.dadm.2018.11.003 ↗
- Languages:
- English
- ISSNs:
- 2352-8729
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 18015.xml